StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report report published on Thursday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Trading Up 8.7 %
Ampio Pharmaceuticals stock opened at $0.25 on Thursday. The company has a fifty day simple moving average of $0.60 and a 200-day simple moving average of $1.52. The stock has a market cap of $285,000.00, a P/E ratio of -0.02 and a beta of 2.14. Ampio Pharmaceuticals has a 12-month low of $0.14 and a 12-month high of $8.30.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last announced its quarterly earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share (EPS) for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Trading Halts Explained
- MarketBeat Week in Review – 5/20 – 5/24
- 3 REITs to Buy and Hold for the Long Term
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
